An Open Label Trial Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetic Profile of Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients
Clinical trial NCT05501574 · TERMINATED
Trial details
- NCT number
- NCT05501574
- Sponsor
- TFF Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-18
- Primary completion
- 2024-10-29
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.